Interview with the CEO and CTO of CPTx, Hendrik Dietz and Christian Sigl

The CTO of CPTx, Christian Sigl is talking about their revolutionary platform technology centered on creating DNA nanostructures. CPTx’s current focus is the infectious disease space, creating a therapeutic platform to neutralize virus infections, starting with influenza. The company is building nanometer sized backbone that are armed with a virus-binding molecule to trap and neutralize virus particles making them incapable of infecting other cells.

Read the Bioneex Story with CPTx